AVE 33.3% 0.2¢ avecho biotechnology limited

oxymorphone patch m eets phase 1 end points, page-21

  1. 34,916 Posts.
    lightbulb Created with Sketch. 480
    Yes TL, cash on the bottom line required to drive the share price upwards. Would require some indications of likely dollars otherwise it's late August before we see the next set of financials.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.